Adaptimmune Therapeutics plc (ADAP) slipped -8.66% or -0.38 to $4.01. It is near 314628 shares traded, which is 118.46% compare to the average total volume 265594. The market cap of ADAP is $419.81 million. The year to date change is -29.41%. The 52 week price range is from $3.6 to $14.62. Price of ADAP have changed -5.39% during last week. It have changed -6.20% over last month, -23.65% over last 3 months, -59.58% over last 6 months and -44.43% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ADAP is 4.91. It is 22.44% above current price. The 200-day Moving Averages for ADAP is 8.73. It is 117.71% above current price. The 52-week High is 14.62. It is 264.59% from the current price. The 52-week Low is 3.6. It is -10.22% from current price.
There are some statistics of ADAP. It is has market cap $419.81 million. The share outstanding is 104.69 million. The average volume is 265594. The percent of top 15 Institution holding is 73.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ADAP is -42.46%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ADAP is -34.24%.